Dr. Rahul Wagh
Home About Specialisations Testimonials Contact
Chat on WhatsApp Book Appointment
Home / Specialisations / Precision Oncology in Pune
Precision Oncology, Pune

Precision Oncology Specialist in Pune, Dr. Rahul Wagh

Precision oncology, also known as personalised medicine, is a revolutionary approach to cancer treatment that tailors therapy based on the specific genetic, molecular, and cellular characteristics of each patient's tumour. Rather than treating all cancers of the same type in the same way, precision oncology identifies the unique molecular drivers of each tumour and targets them with specific therapies, maximising efficacy and minimising unnecessary toxicity.

15+ Years Experience 5000+ Surgeries Baner, Pune
Precision Oncology in Pune Dr Rahul Wagh
5000+
Surgeries
37+
Cancer Types
15+
Years
2
Baner Locations

What is Precision Oncology?

Precision oncology, also known as personalised medicine, is a revolutionary approach to cancer treatment that tailors therapy based on the specific genetic, molecular, and cellular characteristics of each patient's tumour. Rather than treating all cancers of the same type in the same way, precision oncology identifies the unique molecular drivers of each tumour and targets them with specific therapies, maximising efficacy and minimising unnecessary toxicity.

Dr. Rahul Wagh integrates precision oncology principles into his surgical practice in Pune. He routinely incorporates molecular profiling, biomarker testing, and next-generation sequencing (NGS) into the evaluation of complex cancer cases, particularly for GISTs (KIT/PDGFRA testing), colorectal cancer (KRAS, NRAS, BRAF, MSI status), lung cancer (EGFR, ALK, ROS1), and breast cancer (HER2, ER, PR, BRCA status), to ensure that surgical decisions are guided by molecular evidence.

At his Baner clinics, Dr. Wagh positions surgery as part of a precision oncology continuum. He coordinates targeted therapy, immunotherapy, and neoadjuvant precision treatments with medical oncologists in Pune, ensuring that patients derive maximum benefit from both systemic and surgical components of their cancer care, a truly modern, biomarker-driven approach to cancer treatment.

Warning Signs to Watch For

Precision Oncology in its early stages may not cause obvious symptoms, which is why recognising these warning signs and seeking prompt evaluation in Pune is critical:

1. A cancer diagnosis with an unknown primary site
2. Recurrent cancer despite standard chemotherapy
3. A rare cancer type without a clear standard treatment
4. A family history suggesting hereditary cancer syndrome (BRCA, Lynch)
5. A cancer that has not responded to initial therapy
6. Seeking a second opinion on cancer treatment in Pune
7. Request for molecular tumour profiling
8. Interest in clinical trial participation

Why Choose Dr. Rahul Wagh for Precision Oncology in Pune?

MCH Surgical Oncology

Highest qualification in surgical oncology with specialised fellowship training in robotic-assisted and laparoscopic cancer surgery, rare expertise available in Pune.

Oncoplastic Techniques

Breast-conserving surgeries that combine tumour removal with immediate aesthetic reconstruction, prioritising both oncological safety and quality of life.

Robotic Precision

Robotic-assisted surgery provides greater accuracy, smaller incisions, reduced blood loss and a significantly faster recovery compared to open surgery.

5000+ Proven Surgeries

A track record of successful outcomes across 5000+ cancer surgeries. Trusted by patients from Baner, Aundh, Wakad, Hinjewadi and across Pune.

Precision Oncology Surgical Treatment Options in Pune

Dr. Rahul Wagh offers the following surgical treatment options at his clinics in Baner, Pune:

Molecular Tumour Profiling & NGS
Comprehensive genomic sequencing of tumour DNA to identify actionable mutations and guide treatment
Biomarker-Guided Surgical Decision
Use of molecular markers (MSI status, HER2, KRAS, BRCA) to determine surgical approach and extent
Neoadjuvant Targeted Therapy + Surgery
Administration of targeted agents pre-operatively to maximise surgical resectability
BRCA-Guided Surgery
Risk-reducing or therapeutic surgical decisions informed by BRCA1/2 mutation status
MSI/MMR Testing for Lynch Syndrome
Mismatch repair testing for patients with colorectal or endometrial cancer to identify Lynch syndrome
Liquid Biopsy for Surgical Monitoring
Circulating tumour DNA (ctDNA) testing to monitor surgical response and detect early recurrence

Your Precision Oncology Treatment Journey in Pune

1

Molecular Consultation at Baner

Tumour biopsy for NGS and biomarker panel, germline testing if hereditary syndrome suspected.

2

Molecular Tumour Board Review

Discussion of genomic findings with oncologists and pathologists to identify actionable targets.

3

Precision

Guided Surgery, Surgical approach informed by molecular findings, extent, timing, and technique optimised.

4

Targeted Adjuvant Therapy Coordination

Post-surgery targeted therapy or immunotherapy coordinated based on molecular profile.

Other Cancer Types Treated by Dr. Rahul Wagh in Pune

In addition to breast cancer, Dr. Wagh provides expert surgical oncology care for the following cancer types in Pune:

Frequently Asked Questions, Precision Oncology in Pune

Precision oncology is an approach to cancer treatment that uses the molecular characteristics of a patient's tumour to select the most effective treatment. It involves genetic testing, biomarker analysis, and targeted therapies tailored to each individual's cancer.
NGS is a technology that analyses hundreds to thousands of genes simultaneously from a tumour sample, identifying mutations that can be targeted with specific drugs or inform surgical decisions.
Yes. Dr. Rahul Wagh at Baner, Pune integrates molecular profiling and precision oncology principles into the surgical management of cancer, coordinating with medical oncologists and pathologists in Pune.
A liquid biopsy analyses circulating tumour DNA (ctDNA) in blood to detect cancer mutations, monitor treatment response, and identify early recurrence, without the need for an invasive tissue biopsy.
Molecular information can guide the timing of surgery (after targeted neoadjuvant therapy to shrink the tumour), the extent of surgery (e.g., BRCA-guided risk-reducing surgery), and post-operative treatment decisions.